−0.9490SEK
−23.74 MSEK
About STAYBLE THERAPEUTICS AB
Sector
CEO
Andreas Gerward
Headquarters
Gothenburg
Website
Founded
2015
ISIN
SE0013513652
FIGI
BBG00RM5KZR5
Stayble Therapeutics AB engages in the development of pharmaceutical products. It develops an injectable treatment against chronic low back pain triggered by disc degeneration. The company was founded by Kjell Olmarker, Mattias Münnich, and Andreas Gerward in 2015 and is headquartered in Gothenburg, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of STABL is 0.2370 SEK — it has decreased by 8.49% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange STAYBLE THERAPEUTICS AB stocks are traded under the ticker STABL.
STABL stock is 18.54% volatile and has beta coefficient of 0.66. Check out the list of the most volatile stocks — is STAYBLE THERAPEUTICS AB there?
Yes, you can track STAYBLE THERAPEUTICS AB financials in yearly and quarterly reports right on TradingView.
STABL stock has risen by 1.72% compared to the previous week, the month change is a 4.41% rise, over the last year STAYBLE THERAPEUTICS AB has showed a 86.61% decrease.
STABL net income for the last quarter is −6.29 M SEK, while the quarter before that showed −7.04 M SEK of net income which accounts for 10.72% change. Track more STAYBLE THERAPEUTICS AB financial stats to get the full picture.
Today STAYBLE THERAPEUTICS AB has the market capitalization of 8.22 M, it has increased by 1.02% over the last week.
No, STABL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, STABL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STAYBLE THERAPEUTICS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STAYBLE THERAPEUTICS AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STAYBLE THERAPEUTICS AB stock shows the sell signal. See more of STAYBLE THERAPEUTICS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.